1. The Mechanism by Which WBH Enhances Antibiotic Efficacy

*Whole-Body Hyperthermia (WBH)* is utilized as an adjuvant therapy for resistant infections, particularly Lyme Disease (Borreliosis), due to its *synergistic effect* with antibiotics [1, 2]. In vitro studies have shown that a slight increase in core body temperature enhances the *susceptibility* of the Borrelia burgdorferi bacterium to key antibiotics, such as *Ceftriaxone* and *Penicillin* [1]. Furthermore, raising the temperature to an extreme fever range directly targets the *thermophilicity of the spirochete* [2].

In Vitro Evidence and Clinical Rationale

• *Increased Bacterial Susceptibility:* Studies indicate that raising the temperature from 36°C to 38°C (within the physiological fever range) can increase the *antibiotic susceptibility* of Borrelia burgdorferi by up to *16-fold* [1]. This is particularly crucial in tissues where high antibiotic concentrations are difficult to achieve (e.g., the blood-brain barrier).
• *Spirochete Thermolability:* The Borrelia burgdorferi bacterium is *thermolabile, meaning it cannot tolerate high temperatures. The *Extreme Hyperthermia* protocol (above 41°C) is applied in specialized clinics to cause *direct damage* and eliminate persistent and cystic forms of the bacteria [2].
• *Immune Activation:* WBH at fever-range levels not only weakens the bacteria but also *activates the host’s immune system*, including macrophages, which are essential for microbial elimination.

2. WBH as an Adjuvant in Chronic Neuroborreliosis

The efficacy of WBH is particularly relevant in Chronic Neuroborreliosis, where the Borrelia bacterium can persist in the nervous system and other hard-to-reach tissues:

• *Enhanced Penetration:* Elevated temperature increases blood flow and the *permeability of cell membranes* and barriers (such as the blood-brain barrier), facilitating the penetration of antibiotics into tissues where access is normally limited.
• *Cystic Targeting:* It is theorized that thermal stress helps disrupt the survival forms (cysts) of Borrelia and the *biofilms* they form, thus increasing their vulnerability to drug action.

Scientific and Clinical References (E-E-A-T)

1. Reisinger E., Wendelin I., Gasser R., Halwachs G., Truschnig M.W., Krejs G. Antibiotics and Increased Temperature against Borrelia burgdorferi In Vitro. Scand J Infect Dis 1996; 28:155-57.
2. Clinical Protocols: Rationale based on the thermolability of Borrelia burgdorferi (susceptible to cell death at temperatures ≥ 41.6°C / 106.8°F) and enhanced drug penetration. (Secondary specialized clinic references, e.g., St. Georg Klinik, Verthermia).

1. WBH in Psoriatic Arthritis (PsA): Modulating Inflammation and Improving Symptoms

*Iterative Whole-Body Hyperthermia (WBH), utilizing water-filtered Infrared-A wIRA radiation, is an effective adjuvant therapy for Psoriatic Arthritis (PsA). A *controlled, randomized, prospective study* confirmed its beneficial effects [3]. The mechanism of action includes a *sustained reduction in polymorphonuclear granulocyte activity*, suggesting a decrease in systemic inflammation and a lasting improvement in symptoms for patients with rheumatic conditions [2].

Clinical and Immunological Evidence

• *RCT Evidence in PsA:* The high-quality study validated the effects of WBH on Psoriatic Arthritis patients, providing a solid framework for including hyperthermia as part of a multimodal therapeutic strategy [3].
• *Reduction of Inflammatory Activity:* Treatment with mild wIR-A hyperthermia led to a *sustained decrease in the activity of polymorphonuclear granulocytes* in patients with rheumatic diseases [2]. Granulocytes are key cells in the acute and chronic inflammatory processes associated with rheumatism.
• *Degenerative Rheumatism:* WBH with  wIR-A radiation has also been investigated for its effects in *degenerative rheumatic diseases* and *soft tissue rheumatism*, demonstrating its therapeutic potential across various rheumatic conditions [1].

2. WBH in Rheumatism Treatment: Applications and Benefits

Beyond PsA, clinical experiences indicate an extended role for WBH in rheumatic conditions.

• *Soft Tissue Rheumatism:* WBH has proven beneficial in the treatment of conditions involving *soft tissue rheumatism* [1], offering a physical alternative for managing localized pain and inflammation.
• *Adjuvant Physical Therapy:* These results position WBH as a valuable *adjuvant physical therapy* that can be used to reduce systemic inflammatory load and improve the functional status of rheumatic patients.

Scientific References (E-E-A-T)

1. Kopp S., Faber E., Laser T. Erfahrungen mit durch wasser­gefilterte Infrarot-A-Strahlung erzeugter moderater Ganzkörper­hyperthermie bei degenerativ rheumatischen Erkrankungen und Weichteilrheumatismus. Vortrag auf der Medizinischen Woche Baden-Baden 28.10.1995
2. Meffert H., Müller G.M., Scherf H.P. Milde Infrarot-A-Hyperthermie zur Behandlung von Erkrankungen des rheumatischen Formenkreises – Anhaltende Verminderung der Aktivität polymorphkerniger Granulozyten. Intern Sauna-Arch1993; 4:125-31
3. Lange U., Schwab F., Müller-Ladner U., Dischereit G. Wirkung iterativer Ganzkörperhyperthermie mit wassergefilterter Infrarot-A-Strahlung bei Arthritis psoriatica – eine kontrollierte, randomisierte, prospektive Studie. Akt Rheumatol 2014; 05:310-16

1. How Does WBH Influence Growth Hormone (GH) and Prolactin (PRL) Responses?

*Whole-Body Hyperthermia (WBH)* is a potent modulator of the *Hypothalamic-Pituitary-Adrenal (HPA) axis, demonstrating a clear influence on *hormonal responses* [1, 2]. Specialized studies indicate that warm immersions (partial or whole-body), which induce hyperthermia, stimulate the release of *Growth Hormone (GH)* and *Prolactin (PRL). These hormonal responses are part of the body’s complex physiological reaction to thermal stress, an essential mechanism in the *physiology and endocrinology of stress* [3].

Clinical and Physiological Evidence (Endocrinology)

• *GH and PRL Response:* Warm immersions, whether partial or whole-body, demonstrate the capacity to induce *significant responses* in *Growth Hormone* and *Prolactin* [1].
• *Thermal Induction Methods:* These effects have been observed not only through warm water immersions but also through the application of *thermal mud* [2], confirming that the induced *hyperthermia*, regardless of modality, is the trigger.
• *Sympathoadrenal Regulation:* Whole-body hyperthermia (induced by thermal water, for example) activates the *sympathoadrenal regulation* of circulatory responses, suggesting a link between the thermal response, the autonomic nervous system, and endocrine function [3].

2. WBH and the Potential for Type 1 Diabetes Prevention

In addition to hormonal effects, *Fever-Range Whole-Body Hyperthermia (WBH)* has shown therapeutic potential in autoimmune diseases, such as Type 1 Diabetes. Preclinical research indicates that WBH can *prevent the onset of Type 1 Diabetes* in non-obese diabetic (NOD) mice [4]. This preventative effect is attributed to WBH’s capacity to modulate the *immune response* and protect pancreatic cells from autoimmune attack, opening the door for future human studies.

Evidence in Autoimmune Diseases (Type 1 Diabetes)

• *Diabetes Prevention:* The study conducted on NOD mice demonstrated that fever-range WBH can *prevent the establishment of Type 1 Diabetes* [4].
• *Immunomodulatory Mechanism:* This effect suggests that controlled thermal stress may have a beneficial impact on the *systemic inflammation and immune response* underlying autoimmune pathology.

Scientific References (E-E-A-T)

1. Koska J., Rovensky J., Zimanova T., Vigas M. Growth hormone and prolactin responses during partial and whole body warm-water immersions. Acta Physiol Scand. 2003 May;178(1):19-23. PubMed PMID: 12713511
2. Vigas M., Rovensky J., Zimanova T., Koska J. Responses of growth hormone and prolactin to local and whole-body application of Piestany mud. Acta Rheumatol et Balneol Pistiniana 2002:31-38
3. Koska J., Rovensky J., Zimanova T., Ksinantova L., Kvetnansky R., Vigas M. Sympathoadrenal regulation of circulatory responses to whole-body hyperthermia induced by the application of Piestany thermal water and thermal mud. Acta Rheumatol et Balneol Pistiniana 2002:23-30
4. Capitano M.L, Ertel B.R., Repasky E.A., Ostberg J.R. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice. Int J Hyperthermia 2008; 2:141-49.

1. Molecular Mechanisms: WBH and the Induction of Ferritin for Skin Repair

Infrared Radiation (IR), a primary mode of heat delivery in *Whole-Body Hyperthermia (WBH) devices, has been shown to induce the protective protein *Ferritin* in tissue [1]. This induction has significant implications for *skin repair* and cellular protection. Ferritin acts as a potent *antioxidant*, helping cells manage oxidative stress, which is crucial during the recovery phase following tissue damage or in chronic wound environments.

Key Findings in Dermatology and Tissue Protection

• *Ferritin Induction:* Studies confirm that exposure to infrared radiation leads to the *induction of the putative protein ferritin* [1].
• *Skin Repair Implication:* Since ferritin acts as a cellular protectant, its induction suggests a mechanism by which IR-mediated WBH can *support and accelerate skin repair processes* and resilience against stress.
• *Chronic Wound Therapy:* wIR-A Hyperthermia has been explored as a novel therapy concept for *Ulcus Cruris* (venous leg ulcers) [2], indicating its beneficial effects on local microcirculation and healing in chronic, non-healing wounds.

2. WBH in Surgical Settings: Preventing Wound Infection

Using *systemic hyperthermia* (via *preoperative warming) is a critical intervention for reducing Surgical Site Infections (SSIs). A randomized controlled trial published in The Lancet demonstrated that *preoperative warming* significantly lowered the incidence of *wound infection* after clean surgery [3]. Maintaining normothermia or inducing mild hyperthermia supports immune function and improves wound perfusion, both essential factors for minimizing postoperative infection risk [4].

Evidence in Pathology and Post-Operative Care

• *Infection Rate Reduction:* The use of *preoperative warming* (a form of controlled WBH) is a proven strategy to minimize the risk of wound infection following surgery [3].
• *Systemic and Local Application:* Both local and systemic hyperthermia are beneficial in the surgical context [4]. The systemic effect of WBH optimizes the entire body’s capacity to fight infection and heal.

Scientific References (E-E-A-T)

1. Applegate L.A., Scaletta C., Panizzon R., Frenk E., Hohlfeld P., Schwarzkopf S. Induction of the putative protein ferritin by infrared radiation: Implications in skin repair. Int J of Molecular Med 2000; 5:247-51
2. Biland .L, Barras J.P. Das Ulcus cruris – ein neues Therapiekonzept: Wärmetherapie mit wassergefilterter Infrarot-A-Strahlung. 39. Jahrestagung der Dt Ges Phlebol, Bonn, 1.-4.10.1997
3. Melling A.C., Ali B., Scott E.M., Leaper D.J. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomised controlled trial. Lancet 2001; 358:876-80 [pubmed]
4. Kurz A. Local and Systemic Hyperthermia in Surgical Patients. Soc for Thermal Med Joint Annual Meeting, Washington DC, 14.-17.5.2007

1. Whole-Body Hyperthermia (WBH): A Single Session for Rapid Antidepressant Effects

The *Whole-Body Hyperthermia (WBH) treatment* has been validated as a *rapid-acting antidepressant* for patients with *Major Depressive Disorder (MDD)* [1]. A randomized clinical trial demonstrated that a *single session of WBH* can produce a significant and sustained *reduction in depressive symptoms* for several weeks. This non-pharmacological approach works by safely elevating the core body temperature to fever-range levels, triggering neurobiological and physiological responses beneficial for mood regulation.

Key Findings from the Randomized Clinical Trial

The landmark RCT (Janssen et al., 2016) comparing WBH with a sham control procedure provided strong evidence for its efficacy:

• *Sustained Symptom Reduction:* Patients who received the WBH treatment showed a statistically significant and lasting *reduction in depressive symptoms* compared to the control group.
• *Rapid Onset:* The treatment is characterized by its *rapid onset of action*, distinguishing it from traditional antidepressants that typically require several weeks to reach efficacy.
• *Mechanism Hypothesis:* The rapid effect is hypothesized to be linked to WBH’s ability to activate the hypothalamic-pituitary-adrenal (HPA) axis, modulate *neurotransmitters*, and induce the systemic release of heat shock proteins and anti-inflammatory cytokines, pathways often dysregulated in MDD.

2. WBH’s Role in Psychiatry and Neurobiological Mechanisms

The study places WBH within the emerging field of treatments that target the *body-brain axis* for mood disorders.

• *Non-Pharmacological Approach:* WBH offers a valuable *non-pharmacological option* for MDD patients, particularly those who may be resistant to or intolerant of conventional drug treatments.
• *Biological Foundation:* The efficacy of WBH supports the *”thermal hypothesis”* of depression, which suggests that deficits in thermoregulation and certain inflammatory markers contribute to depressive episodes. WBH temporarily resets these biological processes.
• *Single-Session Treatment:* The finding that profound antidepressant benefits can result from a *single session* is a crucial element that distinguishes WBH from most other established MDD therapies.

Scientific References (E-E-A-T)

1. Janssen C.W., Lowry C.A., Mehl M.R., Allen J.J.B., Kelly K.L., Gartner D.E., Medrano A., Begay T.K., Rentscher K., White J.J., Fridman A., Roberts L.J., Robbins M.L., Hanusch K.U., Cole S.P., Raison C.L. Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder – A Randomized Clinical Trial. JAMA Psychiatry. May 12, 2016. doi:10.1001/jamapsychiatry.2016.1031

1. Efficacy of Infrared-A Mediated Hyperthermia in Scleroderma-Associated Raynaud’s Phenomenon

Clinical research confirms that Whole-Body hyperthermia with wIRA radiation is an *effective method* for the treatment of *Raynaud’s Phenomenon (RP)* associated with *Systemic Sclerosis (Scleroderma)* [1]. By utilizing *Mild WB Hyperthermia (Mild wIR-A hyperthermia)*, the treatment targets the *vasoconstrictive symptoms* of RP, contributing to improved *microcirculation* and the management of the autoimmune skin and organ condition [2, 3]. These treatments represent an important *adjuvant therapy* in the complex management of scleroderma.

Mechanisms and Clinical Evidence

Clinical evidence regarding the use of Mild wIR-A Hyperthermia in Systemic Sclerosis (SS) and RP highlights the following:

• *Raynaud’s Phenomenon Treatment:* Specialized studies have demonstrated that *Infrared-A Mediated Hyperthermia* is effective in directly treating *Scleroderma-Associated Raynaud’s Phenomenon*, a critical component of the disease affecting peripheral circulation [1].
• *Systemic Sclerosis Amelioration:* Mild wIR-A Hyperthermia has been investigated as a treatment for *Systemic Sclerosis* itself, showing therapeutic potential in ameliorating symptoms and manifestations of the disease [3].
• *Controlled Technology:* Application is carried out using *computer-controlled wIR-A Hyperthermia*, which allows for precise and specific heat dosage to achieve optimal effect on affected tissues and microcirculation [2].

Scientific References (E-E-A-T)

1. How WBH Improves Functional Health and Modulates Cytokines in Ankylosing Spondylitis (AS)

Iterative *Mild Whole-Body Hyperthermia (WBH)* using water-filtered IR-A radiation wIRA is a proven adjuvant therapy for Ankylosing Spondylitis (AS), validated by *controlled, randomized, prospective studies* [4]. The key mechanism is immunomodulation, where WBH significantly *increases anti-inflammatory cytokines* like *Interleukin-10 (IL-10)* while affecting pro-inflammatory mediators (TNF-alpha, IL-6) [3, 1]. This results in *improved functional and subjective health* for AS patients [2, 4].

Immunological and Functional Outcomes

• *Anti-Inflammatory Response (IL-10):* WBH treatment has been shown to *increase Interleukin-10 (IL-10)* expression in AS patients, along with Toll-Like Receptor 4, suggesting a beneficial shift toward an anti-inflammatory state [3].
• *Pro-Inflammatory Cytokines:* Studies confirm that mild WBH affects systemic levels of pro-inflammatory cytokines, specifically *TNF-alpha, IL-1 beta and IL-6*, which are key drivers of AS pathology [1].
• *Functional Health Improvement:* Research from the Justus-Liebig-Universität Gießen demonstrated that iterative WBH positively impacts the *functional and functional health* status of patients with AS [2].
• *High-Level Evidence:* The efficacy of iterative WBH with water-filtered IR-A radiation (wIRA hyperthermia) in AS is confirmed by a *controlled, randomized, prospective study* [4].

References (E-E-A-T)

1. Tarner I.H., Ladner U.M., Uhlemann C., Lange U.
   The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1 beta and IL-6 in patients with ankylosing spondylitis.
   Clin Rheumatol 2009; 4:397-402
2. Neumann S.
   Wirkung der iterativer Ganzkörperhyper­thermie mit wassergefilterter Infrarot-A-Strahlung auf die funktionelle und funktionale Gesundheit sowie pro- und anti- inflamatorische Zytokine bei Patienten mit ankylosierender Spondylitis
   Diss. Justus-Liebig-Universität Gießen, Internist. Rheumatol. 2011
3. Zauner D., Quehenberger F., Hermann J., Dejaco C., Stradner M.H., Stojakovic T., Angerer H., Rinner B., Graninger W.B.
   Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis: A pilot study
   Int J Hyperthermia 2014; 6:393-401, Volltext-Link
4. Lange U., Müller-Ladner U., Dischereit G.
   Wirkung iterativer Ganzkörperhyperthermie mit wassergefilterter Infrarot-A-Strahlung bei ankylosierender Spondylitis – eine kontrollierte, randomisierte, prospektive Studie
   Akt Rheumatol 2017; 2:122-128

1. Efficacy of Mild WBH in Reducing Fibromyalgia Pain and Improving Mental Health

*Mild Whole-Body Hyperthermia (WBH)* with water-filtered Infrared-A is proven to be an effective *adjunct treatment* for *Fibromyalgia Syndrome (FMS), confirmed by *Randomized Controlled Trials (RCT)* [1, 2]. Serial WBH treatments significantly *reduce pain intensity* and provide measurable *improvements in the patient’s mental state* [6, 5]. Whole Body Hyperthermia’s mechanism is thought to address underlying pathologies such as *microcirculation abnormalities* and potential *small fiber pathology* [3, 7].

Clinical and Physiological Findings

• *Pain Reduction & Mental State:* Controlled studies show that integrating systemic WBH into multi-modal FMS therapy provides significant benefits, primarily reducing *pain intensity* and achieving a positive impact on the *mental state* [6, 5].
• *Randomized Controlled Trial (RCT) Evidence:* RCTs confirm the effectiveness and tolerability of mild WBH as an adjunct to standard multimodal rehabilitation for FMS [1, 2].
• *Addressing Underlying Pathology:* Research indicates that FMS patients often exhibit *microcirculation abnormalities* (measured by capillary and laser fluxmetry) [3] and *small fiber pathology* [7], both of which are targeted by the physiological effects of WBH (improved blood flow).
• *Iterative Treatment:* Iterative mild WBH protocols have been shown to positively impact FMS pain over a treatment series [4].

References (E-E-A-T)

1. Brockow T., Wagner A., Franke A., Offenbächer M., Resch K.L.
   A Randomized Controlled Trial on the Effectiveness of Mild Water-filtered Near Infrared Whole-body Hyperthermia as a n Adjunct to a Standard Multimodal Rehabilitation in the treatment of Fibromyalgia.
   Clin J Pain 2007; 1:67-75
2. Eine randomisierte, kontrollierte Studie zur Wirksamkeit und Ver­träglichkeit einer milden wassergefi lterten Infrarot-A-Ganz­körperhyperthermie als Zusatzbehandlung zu einer multimo­dalen rehabiliitativen Standardtherapie bei der Behandlung der Fibromyalgie.
   Phys Med Rehab Kuror 2008; 18:171-80
3. Morf S., Vesti B.A., Forster A., Franzeck U.K., Koppensteiner R., Uebelhart D., Sprott H.
   Microcirculation abnormalities in patients with fibromyalgia – measured by capillary and laser fluxmetry.
   Arthritis Res Ther 2005; 7:R209-16, Volltext-Link
4. Schleenbecker H.G., Schmidt K.L.
   Zur Wirkung einer iterativen milden Ganzkörperhyperthermie auf den Fibromyalgieschmerz.
   Phys Rehab Kur Med 1998; 8:113-17
5. Walz J., Hinzmann J., Haase I., Witte T.
   Ganzkörperhyperthermie in der Schmerztherapie – eine kontrollierte Studie an Patienten mit Fibromyalgiesyndrom.
   Schmerz 2013; 27:38-45
6. Romeyke T., Stummer H.
   Multi-modal pain therapy of fibromyalgia syndrome with integration of systemic whole-body hyperthermia – effects on pain intensity and mental state: A non-randomised controlled study.
   J Musculoskel Pain 2014; 4:341-55
7. Üceyler N., Zeller D., Kahn A.K., Kewenig S., Kittel-Schneider S., Schmid A., Casanova-Molla J., Reiners K., Sommer C.
   Small fibre pathology in patients with fibromyalgia syndrome
   Brain 2013; 136:1857–67

1. WBH in Multimodal Pain Therapy for Chronic Non-Specific Low Back Pain

Mild Whole-Body Hyperthermia (WBH), often mediated by water-filtered Infrared-A (IR-A), serves as an effective adjuvant component in *stationary multimodal pain therapy* for patients suffering from *chronic non-specific low back pain (Dorsalgia)* [2]. By inducing controlled, therapeutic heat, WBH supports muscle relaxation, improves local perfusion, and provides an important, non-pharmacological pathway for managing pain, particularly in cases involving *analgesic abuse* [1].

Clinical Evidence and Application

The role of WBH in treating chronic back pain is supported by focused clinical evaluations:

• *Multimodal Integration:* A dedicated evaluation confirmed that *mild WBH* combined with stationary multimodal pain therapy showed positive outcomes in patients with *chronic non-specific lumbar back pain* [2].
• *Addressing Analgesic Abuse:* Studies have specifically explored the application of wIRA hyperthermia in patients presenting with *analgesic abuse* due to chronic back pain, suggesting its role as a necessary intervention to reduce pharmacological dependency [1].
• *Mechanism:* The physical effects of heat—muscle relaxation and increased local circulation—are central to its efficacy in managing this type of musculoskeletal pain.

References (E-E-A-T)

1. Weller E., Ullrich D.
   Infrarot-A-Hyperthermie-Anwendung bei Patienten mit Analgetica-Abusus wegen chronischer Rückenschmerzen.
   Vortrag auf dem 95. Kongreß der Gesellschaft für Phys Med und Rehab 5.10.1990
2. Ettrich U., Konrad B., Prate K., Seifert J., Krummenauer F.
   Milde Ganzkörperhyperthermie in Kombination mit stationärer multimodal orientierter Schmerztherapie – Evaluation bei Patienten mit chronischem unspezifischem lumbalem Rückenschmerz.
   Orthopäde 2014; 2:165-74

1. How Does Mild Infrared-A (IR-A) Hyperthermia Influence Primary Hypertension?

Mild Whole-Body Hyperthermia (WBH), mediated by water-filtered Infrared-A IR-A radiation(wIRA hyperthermia), acts as an adjuvant physical therapy for patients with *Essential Arterial Hypertension* (WHO stages I and II). Clinical studies indicate that serial WBH sessions positively impact  central and peripheral pulse waves, blood pressure, and the flow properties of blood (viscosity), suggesting an overall improvement in hemodynamics and circulatory health [1, 4].

Mechanisms of Action in Arterial Hypertension

Research on the effects of WBH (especially in the *mild* regimen, below 38.5  degrees C ) has highlighted the following clinical and physiological benefits:

1. Pulse Wave Modulation: A series of mild IR-A treatments demonstrated the ability to favorably influence *central and peripheral pulse waves* in hypertensive patients, indicating a potential improvement in vascular elasticity [1].
2. Blood Viscosity Reduction: A single WBH session has shown a direct influence on blood viscosity, as well as on *heart rate* and *blood pressure* in patients with Hypertension stages I and II [4].
3. Serial Therapeutic Effect: Serial irradiations with water-filtered IR-A have been investigated for their effects on patients with Arterial Hypertension, underscoring the role of this method as a valid *physical therapy* [2].
4. Predictability of Response: A single mild  IR-A hyperthermia session can be used to make *predictions* regarding a patient’s response to a complete therapeutic cycle (further treatments) [5].

2. WBH in Hypertension Treatment (WHO Stages I and II)

Studies have focused on patients diagnosed with *Essential Arterial Hypertension* (Types I and II, according to the WHO classification).

• Target Group: Research included patients in the *early and moderate stages* of hypertension, showing clear benefits in the context of an adjuvant treatment [2, 3].
• Physiological Monitoring: Essential physiological parameters, including body temperature, heart rate, blood pressure, and blood viscosity, were closely monitored during and after treatment to quantify acute and cumulative effects [4].
• Academic Dissertation: A dedicated study (Diss. Humboldt-Universität Berlin, 1991) specifically analyzed the effects of a single versus serial sessions of *Infrared-A Hyperthermia* in HTA Stages I and II patients [3].

Overview of recommended WBH sessions with von Ardenne Iratherm 1000 WBH wIRA device and target temperatures

Treatments shall only be performed after final consultation with a medical doctor

Scientific References (E-E-A-T)

1. Meffert B., Hochmuth O., Steiner M.
   Effects of a multiple mild infrared a induced hyperthermia on central and peripheral pulse waves in hypertensive patients.
   North Sea Conference on Biomedical Engineering 1990, >Abstract
2. Meffert H., Scherf HP., Meffert B.
   Milde Infrarot-A-Hyperthermie. Auswirkungen von Serienbestrahlungen mit wassergefilterter Infrarotstrahlung auf Gesunde und Kranke mit arterieller Hypertonie bzw. systemischer Sklerodermie.
   Akt Dermatol 1993; 19:142-48, >Abstract, Volltext-Link
3. Mischke M.
   Wirkungen einer einmaligen bzw. seriellen Infrarot-A-Hyperthermie bei Patienten mit arterieller Hypertonie der WHO-Stadien I und II.
   Diss. Humboldt-Universität Berlin 18.07.1991
4. Scherf H.P., Meffert H., Bäumler H., Dittmann K., Siewert H., Strangfeld D., Winterfeld H.J., Hecht H.C., Schuhmann E., Sönnichsen N.
   Wirkung einer einmaligen milden Infrarot-A-Hyperthermie auf Körpertemperatur, Herzfrequenz, Blutdruck und Blutviskosität bei Gesunden und Patienten mit arterieller Hypertonie der Stadien I und II.
   Dermatol Monatsschr 1989; 175:733-40, >Abstract
5. Scherf H.P., Meffert H., Mischke M., Schollak K.P.
   Physikalische Therapie der arteriellen Hypertonie- Eine einmalige milde Infrarot-A-Hyperthermie gestattet Voraussagen hinsichtlich des nsprechens auf weitere Behandlungen.
   Phys Rehab Kur Med 1991; 1:38-40, >Abstract